Clinical Trials
2 trialsNCT06423144 2024-05-21
PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7
Shanghai Zhongshan Hospital
Unknown
NCT04639284 2021-07-26
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Shanghai Zhongshan Hospital
Unknown